YU201978A - Process for preparing aminopurine derivatives - Google Patents

Process for preparing aminopurine derivatives

Info

Publication number
YU201978A
YU201978A YU02019/78A YU201978A YU201978A YU 201978 A YU201978 A YU 201978A YU 02019/78 A YU02019/78 A YU 02019/78A YU 201978 A YU201978 A YU 201978A YU 201978 A YU201978 A YU 201978A
Authority
YU
Yugoslavia
Prior art keywords
preparing
aminopurine derivatives
aminopurine
derivatives
preparing aminopurine
Prior art date
Application number
YU02019/78A
Other versions
YU35034B (en
Inventor
Elion B Gertude
B Gertude Elion
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of YU201978A publication Critical patent/YU201978A/en
Publication of YU35034B publication Critical patent/YU35034B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
YU2019/78A 1969-11-17 1978-08-24 Process for preparing aminopurine derivatives YU35034B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87744369A 1969-11-17 1969-11-17

Publications (2)

Publication Number Publication Date
YU201978A true YU201978A (en) 1979-12-31
YU35034B YU35034B (en) 1980-06-30

Family

ID=25369972

Family Applications (2)

Application Number Title Priority Date Filing Date
YU2806/70A YU35033B (en) 1969-11-17 1970-11-16 Process for preparing aminopurine derivatives
YU2019/78A YU35034B (en) 1969-11-17 1978-08-24 Process for preparing aminopurine derivatives

Family Applications Before (1)

Application Number Title Priority Date Filing Date
YU2806/70A YU35033B (en) 1969-11-17 1970-11-16 Process for preparing aminopurine derivatives

Country Status (26)

Country Link
US (1) US3666856A (en)
JP (1) JPS5429520B1 (en)
AT (1) AT309696B (en)
BE (1) BE759011A (en)
BR (1) BR6915136D0 (en)
CA (1) CA967564A (en)
CH (2) CH555344A (en)
CS (1) CS181701B2 (en)
DE (1) DE2056327C2 (en)
DK (1) DK128117B (en)
ES (2) ES385590A1 (en)
FI (1) FI54315C (en)
FR (1) FR2073364B1 (en)
GB (2) GB1338905A (en)
HU (1) HU163812B (en)
IE (1) IE34737B1 (en)
IL (1) IL35658A (en)
LU (1) LU62071A1 (en)
MC (1) MC869A1 (en)
NL (1) NL171589C (en)
NO (1) NO128156B (en)
PL (1) PL81167B1 (en)
SE (1) SE385374B (en)
YU (2) YU35033B (en)
ZA (1) ZA707722B (en)
ZM (1) ZM12970A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4081534A (en) * 1973-09-11 1978-03-28 Burroughs Wellcome Co. Amino purine nucleosides as autoimmune suppressant agents
GB1562899A (en) * 1975-06-17 1980-03-19 Wellcome Found Pharmaceutical compositions containing substituted 9-( -d-arabnofuranosyl)purine-5'-phosphate and salts thereof
US4210745A (en) * 1978-01-04 1980-07-01 The United States Of America As Represented By The Department Of Health, Education And Welfare Procedure for the preparation of 9-β-D-arabinofuranosyl-2-fluoroadenine
DE3319282A1 (en) * 1983-05-27 1984-11-29 Gödecke AG, 1000 Berlin USE OF ADENOSINE IN THE TREATMENT OF HERPES
GB8712745D0 (en) * 1987-05-30 1987-07-01 Wellcome Found Antiviral compounds
ATE128141T1 (en) * 1988-03-16 1995-10-15 Scripps Research Inst SUBSTITUTED ADENINE DERIVATIVES USABLE AS THERAPEUTIC AGENTS.
IE882585L (en) * 1988-08-25 1990-02-25 Prendergast Patrick T Viral treatment system
US5292725A (en) * 1988-08-25 1994-03-08 Prendergast Patrick T Administering particular compounds against various parasites, mycoplasmas, other indications and other infections
US5681941A (en) * 1990-01-11 1997-10-28 Isis Pharmaceuticals, Inc. Substituted purines and oligonucleotide cross-linking
US5308837A (en) * 1990-08-22 1994-05-03 Merrell Dow Pharmaceuticals Inc. 5'-amine substituted adenosine analogs as immunosuppressants
US6338963B1 (en) 1994-07-25 2002-01-15 Neotherapeutics, Inc. Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
US6232463B1 (en) 1997-10-09 2001-05-15 Isis Pharmaceuticals, Inc. Substituted purines and oligonucleotide cross-linking
AU3786299A (en) 1998-05-04 1999-11-23 Neotherapeutics, Inc. Novel serotonin-like 9-substituted hypoxanthine and methods of use
US6288069B1 (en) 1999-11-16 2001-09-11 Neotherapeutics, Inc. Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
WO2002004452A2 (en) 2000-07-07 2002-01-17 Neotherapeutics, Inc. Methods for treatment of disease-induced peripheral neuropathy and related conditions
US6759427B2 (en) * 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
CN105237602B (en) * 2015-06-25 2018-05-18 新乡学院 A kind of preparation method of 2- amino arabinosy ladenosine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3208997A (en) * 1962-11-15 1965-09-28 Sankyo Co Process for preparing purine and pyrimidine nucleosides
US3407191A (en) * 1966-08-29 1968-10-22 Lilly Co Eli Adamantoate esters of nucleosides
JPH1097965A (en) * 1996-09-20 1998-04-14 Sony Corp Production control method

Also Published As

Publication number Publication date
DE2056327A1 (en) 1971-06-03
ES385590A1 (en) 1973-10-01
ZA707722B (en) 1972-06-28
AT309696B (en) 1973-08-27
IE34737L (en) 1971-05-17
FR2073364A1 (en) 1971-10-01
MC869A1 (en) 1971-09-28
GB1338906A (en) 1973-11-28
DK128117B (en) 1974-03-04
NO128156B (en) 1973-10-08
LU62071A1 (en) 1971-08-12
ZM12970A1 (en) 1972-07-21
FI54315B (en) 1978-07-31
IE34737B1 (en) 1975-08-06
CH555833A (en) 1974-11-15
ES413787A1 (en) 1976-01-16
GB1338905A (en) 1973-11-28
YU35033B (en) 1980-06-30
IL35658A0 (en) 1971-01-28
CH555344A (en) 1974-10-31
YU280670A (en) 1979-12-31
BE759011A (en) 1971-05-17
NL171589C (en) 1983-04-18
CS181701B2 (en) 1978-03-31
NL7016766A (en) 1971-05-19
FI54315C (en) 1978-11-10
FR2073364B1 (en) 1974-03-22
HU163812B (en) 1973-10-27
JPS5429520B1 (en) 1979-09-25
NL171589B (en) 1982-11-16
US3666856A (en) 1972-05-30
BR6915136D0 (en) 1973-04-19
SE385374B (en) 1976-06-28
PL81167B1 (en) 1975-08-30
IL35658A (en) 1974-10-22
DE2056327C2 (en) 1984-10-11
CA967564A (en) 1975-05-13
YU35034B (en) 1980-06-30

Similar Documents

Publication Publication Date Title
YU294570A (en) Process for preparing delta-alkylamino-propiophenones
YU3277A (en) Process for preparing quinazoline derivatives
YU35033B (en) Process for preparing aminopurine derivatives
YU40208B (en) Process for preparing morpholine derivatives
YU301070A (en) Process for preparing nphthylalkylamines
YU231769A (en) Process for preparing pyrindol derivatives
YU34537B (en) Process for preparing novel evomonoside derivatives
YU34678B (en) Process for preparing 9-azolyl-fluorne-9-carboxylic acid derivatives
YU33975B (en) Process for preparing bufatrienolide-rhamnoside-acylates
YU4376A (en) Process for preparing 3-amino-2-pyrazoline derivatives
YU309570A (en) Process for preparing digitoxigenin-delta-l-thevetoside derivatives
YU137270A (en) Process for preparing thiamphenicol-glycinate acetylcysteinate
YU33967B (en) Process for preparing lumilysergic acid derivatives
YU34037B (en) Process for preparing novel p-amino-alkylbenzene-sulfonamide derivatives
YU257470A (en) Process for preparing benzodiazepine derivatives
YU34475B (en) Process for preparing 5-hydroxy-or 6-hydroxy-isoquinuclidines
YU144670A (en) Process for preparing substituted shloroacylanilides
YU183770A (en) Process for preparing bis-formamide derivatives
YU34788B (en) Process for preparing 3-chloro-4-n-and-iso-propoxy-ureas
YU201270A (en) Process for preparing phenyl-3-tert.-butyl-5-oxadiazolone-2
YU207170A (en) Process for preparing 5-halo-salicylic acid derivatives
YU140870A (en) Process for preparing substituted 5-nitrofuryl-pyrazole derivatives
CA823204A (en) Process for preparing 3-cyanomethylene-pregnene derivatives
YU166270A (en) Process for obtaining bis-alkanolamine derivatives
YU167369A (en) Process for preparing 9delta-fluoro-16-methylene-prednisolone-21-acetate